AbbVie
This study is to evaluate safety, tolerability, pharmacokinetics and effect of food on ABBV-7828 compared to placebo in healthy adult participants.
Inclusion Criteria: * Individuals between 18 to 65 years of age at the time of screening. * BMI is \<= 18.0 to \>= 32.0 kg/m2. * A condition of general good health, based upon the results of a medical history, physical evaluations, vital signs, laboratory profile and a 12-lead ECG. Exclusion Criteria: * History of epilepsy, any clinically significant cardiac, respiratory (except mild asthma as a child), renal, hepatic, gastrointestinal, hematologic or psychiatric disease or disorder, or any uncontrolled medical illness. * Has any clinically significant ECG abnormalities including the follow…
Oral administration
Oral administration
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.